We serve Chemical Name:5-(Chloromethyl)-2-(4-chlorophenyl)-4-methyl-1,3-thiazole CAS:317319-28-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(Chloromethyl)-2-(4-chlorophenyl)-4-methyl-1,3-thiazole
CAS.NO:317319-28-1
Synonyms:5-(chloromethyl)-4-methyl-2-(4-chlorophenyl)thiazole;5-chloromethyl-2-(4-chlorophenyl)-4-methylthiazole;chloromethylchlorophenylmethylthiazole
Molecular Formula:C11H9Cl2NS
Molecular Weight:258.16700
HS Code:2934100090
Physical and Chemical Properties:
Melting point:109-112ºC
Boiling point:389.7ºC at 760mmHg
Density:1.335g/cm3
Index of Refraction:1.607
PSA:41.13000
Exact Mass:256.98300
LogP:4.51070
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-(chloromethyl)-4-methyl-2-(4-chlorophenyl)thiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,chloromethylchlorophenylmethylthiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(chloromethyl)-4-methyl-2-(4-chlorophenyl)thiazole Use and application,5-(chloromethyl)-4-methyl-2-(4-chlorophenyl)thiazole technical grade,usp/ep/jp grade.
Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 5-(Chloromethyl)-2-(4-chlorophenyl)-4-methyl-1,3-thiazole manufacturer The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 5-(Chloromethyl)-2-(4-chlorophenyl)-4-methyl-1,3-thiazole supplier It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation. 5-(Chloromethyl)-2-(4-chlorophenyl)-4-methyl-1,3-thiazole vendor The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 5-(Chloromethyl)-2-(4-chlorophenyl)-4-methyl-1,3-thiazole factory It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation.
